Key result
Across five European nations, crude implant rates were 104/100,000 for pacemakers and 30.6/100,000 for ICDs, with significant between- and within-country variation persisting from 2008 to 2012.
Observational (n=1,338,199)
Yes
Administrative hospital discharge databases provide a reliable and cost-effective methodology for tracking pacemaker and ICD utilization rates and trends across European countries.
Answers are grounded in this paper and cite their sources.
Persistent geographic variation in device implantation signals potential inequities in access; leaves open drivers of optimal utilization.
Aims: Common methodologies for analysis of analogous data sets are needed for international comparisons of treatment and outcomes. This study tests using administrative hospital discharge (HD) databases in five European countries to investigate variation/trends in pacemaker (PM) and implantable cardioverter defibrillator (ICD) implant rates in terms of patient characteristics/management, device subtype, and initial implantation vs. replacement, and compares findings with existing literature and European Heart Rhythm Association (EHRA) reports. Methods and results: HD databases from 2008 to 2012 in Austria, England, Germany, Italy and Slovenia were interrogated to extract admissions (without patient identification) associated with PM and ICD implants and replacements, using direct cross-referencing of procedure codes and common methodology to compare aggregate data. 1 338 199 records revealed 212 952 PM and 62 567 ICD procedures/year on average for a 204.4 million combined population, a crude implant rate of about 104/100 000 inhabitants for PMs and 30.6 for ICDs. The first implant/replacement rate ratios were 81/24 (PMs) and 25/7 (ICDs). Rates have increased, with cardiac resynchronization therapy (CRT) subtypes for both devices rising dramatically. Significant between- and within-country variation persists in lengths of stay and rates (Germany highest, Slovenia lowest). Adjusting for age lessened differences for PM rates, scarcely affected ICDs. Male/female ratios remained stable at 56/44% (PMs) and 79/21% (ICDs). About 90% of patients were discharged to home; 85-100% were inpatient admissions. Conclusion: To aid in policymaking and track outcomes, HD administrative data provides a reliable, relatively cheap, methodology for tracking implant rates for PMs and ICDs across countries, as comparisons to EHRA data and the literature indicated.
No takes yet. Share an insight, caveat, or question.
Banks et al. (2017) conducted an observational in Cardiac implantable electrical device utilization (n=1,338,199). Cardiac implantable electrical device utilization was evaluated on Crude implant rate per 100,000 inhabitants. Across five European nations, crude implant rates were 104/100,000 for pacemakers and 30.6/100,000 for ICDs, with significant between- and within-country variation persisting from 2008 to 2012.
Synapse has enriched 10 related papers. Consider them for comparative context: